Similar articles for PMID: 20658911

Year	Number of Results
1993	1
1996	1
1997	1
1999	3
2000	3
2002	2
2003	5
2004	1
2005	10
2006	4
2007	4
2008	9
2009	10
2010	12
2011	11
2012	9
2013	12
2014	8
2015	6
2016	4
2017	3
2018	3
2019	3
2020	4
2021	3
2022	3
2023	1
2024	0

1

Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.

Tomaszek SC, Huebner M, Wigle DA. Tomaszek SC, et al. Expert Rev Respir Med. 2010 Aug;4(4):499-508. doi: 10.1586/ers.10.40. Expert Rev Respir Med. 2010. PMID: 20658911 Review.

2

Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?

Buikhuisen WA, Burgers JA, Vincent AD, Schellens JH, Beijnen JH, Smit EF, Joerger M. Buikhuisen WA, et al. J Clin Oncol. 2010 Sep 20;28(27):e482-3; author reply e484. doi: 10.1200/JCO.2010.29.1559. Epub 2010 Jul 6. J Clin Oncol. 2010. PMID: 20606096 No abstract available.

3

"Personalizing" therapy for non-small cell lung cancer.

D'Cunha J. D'Cunha J. Semin Thorac Cardiovasc Surg. 2010 Summer;22(2):118-20. doi: 10.1053/j.semtcvs.2010.08.005. Semin Thorac Cardiovasc Surg. 2010. PMID: 21092888

4

Molecular prognostication of non-small cell lung cancer.

Tsao MS, Jablons DM. Tsao MS, et al. Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):4-7. doi: 10.1053/j.semtcvs.2013.01.007. Semin Thorac Cardiovasc Surg. 2013. PMID: 23800523 No abstract available.

5

Genomic medicine in non-small cell lung cancer: paving the path to personalized care.

Sriram KB, Larsen JE, Yang IA, Bowman RV, Fong KM. Sriram KB, et al. Respirology. 2011 Feb;16(2):257-63. doi: 10.1111/j.1440-1843.2010.01892.x. Respirology. 2011. PMID: 21044232 Review.

6

Molecular biologic staging of lung cancer.

D'Amico TA. D'Amico TA. Ann Thorac Surg. 2008 Feb;85(2):S737-42. doi: 10.1016/j.athoracsur.2007.11.047. Ann Thorac Surg. 2008. PMID: 18222207 Review.

7

A novel molecular staging protocol for non-small cell lung cancer.

Miyake M, Adachi M, Huang C, Higashiyama M, Kodama K, Taki T. Miyake M, et al. Oncogene. 1999 Apr 8;18(14):2397-404. doi: 10.1038/sj.onc.1202556. Oncogene. 1999. PMID: 10327061

8

Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.

Broët P, Camilleri-Broët S, Zhang S, Alifano M, Bangarusamy D, Battistella M, Wu Y, Tuefferd M, Régnard JF, Lim E, Tan P, Miller LD. Broët P, et al. Cancer Res. 2009 Feb 1;69(3):1055-62. doi: 10.1158/0008-5472.CAN-08-1116. Epub 2009 Jan 27. Cancer Res. 2009. PMID: 19176396 Free article.

9

Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K. Zhao ZH, et al. Lung Cancer. 2008 Oct;62(1):113-9. doi: 10.1016/j.lungcan.2008.02.014. Epub 2008 Jun 11. Lung Cancer. 2008. PMID: 18550205

10

Translational research in lung cancer.

Chen Y, Okunieff P, Ahrendt SA. Chen Y, et al. Semin Surg Oncol. 2003;21(3):205-19. doi: 10.1002/ssu.10039. Semin Surg Oncol. 2003. PMID: 14508854 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year